Tanaka, H.; Ueda, K.; Karita, M.; Ono, T.; Manabe, Y.; Kajima, M.; Fujimoto, K.; Yuasa, Y.; Shiinoki, T.
Immune Checkpoint Inhibitors after Radiation Therapy Improve Overall Survival Rates in Patients with Stage IV Lung Cancer. Cancers 2023, 15, 4260.
https://doi.org/10.3390/cancers15174260
AMA Style
Tanaka H, Ueda K, Karita M, Ono T, Manabe Y, Kajima M, Fujimoto K, Yuasa Y, Shiinoki T.
Immune Checkpoint Inhibitors after Radiation Therapy Improve Overall Survival Rates in Patients with Stage IV Lung Cancer. Cancers. 2023; 15(17):4260.
https://doi.org/10.3390/cancers15174260
Chicago/Turabian Style
Tanaka, Hidekazu, Kazushi Ueda, Masako Karita, Taiki Ono, Yuki Manabe, Miki Kajima, Koya Fujimoto, Yuki Yuasa, and Takehiro Shiinoki.
2023. "Immune Checkpoint Inhibitors after Radiation Therapy Improve Overall Survival Rates in Patients with Stage IV Lung Cancer" Cancers 15, no. 17: 4260.
https://doi.org/10.3390/cancers15174260
APA Style
Tanaka, H., Ueda, K., Karita, M., Ono, T., Manabe, Y., Kajima, M., Fujimoto, K., Yuasa, Y., & Shiinoki, T.
(2023). Immune Checkpoint Inhibitors after Radiation Therapy Improve Overall Survival Rates in Patients with Stage IV Lung Cancer. Cancers, 15(17), 4260.
https://doi.org/10.3390/cancers15174260
